• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童中风。

Childhood stroke.

机构信息

Department of Neuroradiology, Clinic of Radiology & Nuclear Medicine, University Hospital Basel, Basel, Switzerland.

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Nat Rev Dis Primers. 2022 Feb 24;8(1):12. doi: 10.1038/s41572-022-00337-x.

DOI:10.1038/s41572-022-00337-x
PMID:35210461
Abstract

Stroke is an important cause of neurological morbidity in children; most survivors have permanent neurological deficits that affect the remainder of their life. Stroke in childhood, the focus of this Primer, is distinguished from perinatal stroke, defined as stroke before 29 days of age, because of its unique pathogenesis reflecting the maternal-fetal unit. Although approximately 15% of strokes in adults are haemorrhagic, half of incident strokes in children are haemorrhagic and half are ischaemic. The causes of childhood stroke are distinct from those in adults. Urgent brain imaging is essential to confirm the stroke diagnosis and guide decisions about hyperacute therapies. Secondary stroke prevention strongly depends on the underlying aetiology. While the past decade has seen substantial advances in paediatric stroke research, the quality of evidence for interventions, such as the rapid reperfusion therapies that have revolutionized arterial ischaemic stroke care in adults, remains low. Substantial time delays in diagnosis and treatment continue to challenge best possible care. Effective primary stroke prevention strategies in children with sickle cell disease represent a major success, yet barriers to implementation persist. The multidisciplinary members of the International Pediatric Stroke Organization are coordinating global efforts to tackle these challenges and improve the outcomes in children with cerebrovascular disease.

摘要

中风是儿童神经功能障碍的重要原因;大多数幸存者都有永久性的神经缺陷,影响他们的余生。本《指南》的重点是儿童中风,它与围产期中风不同,围产期中风定义为 29 天以内的中风,因为其独特的发病机制反映了母婴单位。尽管成年人中风的约 15%是出血性的,但儿童中风的一半是出血性的,一半是缺血性的。儿童中风的病因与成年人不同。紧急脑部成像对于确认中风诊断和指导超急性治疗决策至关重要。二级中风预防强烈取决于潜在病因。尽管过去十年在儿科中风研究方面取得了重大进展,但干预措施的证据质量仍然很低,例如快速再灌注治疗已经彻底改变了成年人的动脉缺血性中风治疗。诊断和治疗的大量时间延迟仍然是对最佳护理的挑战。镰状细胞病患儿的有效一级中风预防策略是一个重大成功,但实施仍存在障碍。国际儿科中风组织的多学科成员正在协调全球努力,以应对这些挑战并改善脑血管疾病患儿的结局。

相似文献

1
Childhood stroke.儿童中风。
Nat Rev Dis Primers. 2022 Feb 24;8(1):12. doi: 10.1038/s41572-022-00337-x.
2
Current treatment for childhood arterial ischaemic stroke.儿童动脉缺血性脑卒中的当前治疗方法。
Lancet Child Adolesc Health. 2021 Nov;5(11):825-836. doi: 10.1016/S2352-4642(21)00167-X. Epub 2021 Jul 29.
3
The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.成人镰状细胞病患者中风的流行病学、评估和治疗。
Expert Rev Hematol. 2011 Dec;4(6):597-606. doi: 10.1586/ehm.11.61.
4
Recent developments in childhood arterial ischaemic stroke.儿童动脉缺血性卒中的最新进展
Lancet Neurol. 2008 May;7(5):425-35. doi: 10.1016/S1474-4422(08)70086-3.
5
Cerebrovascular disease in sickle cell disease.镰状细胞病中的脑血管疾病。
Pract Neurol. 2023 Apr;23(2):131-138. doi: 10.1136/pn-2022-003440. Epub 2022 Sep 19.
6
In pursuit of evidence-based treatments for paediatric stroke: the UK and Chest guidelines.追求儿童卒中的循证治疗:英国与胸科协会指南
Lancet Neurol. 2005 Jul;4(7):432-6. doi: 10.1016/S1474-4422(05)70120-4.
7
[Arterial-ischaemic stroke in childhood].[儿童动脉缺血性卒中]
Ther Umsch. 2012 Sep;69(9):536-42. doi: 10.1024/0040-5930/a000326.
8
Factors predictive of outcome in childhood stroke in an Asian population.亚洲人群中儿童脑卒中结局的预测因素。
Ann Acad Med Singap. 2009 Oct;38(10):876-81.
9
Ischemic strokes in children.儿童缺血性中风。
Indian J Pediatr. 1997 Sep-Oct;64(5):613-23. doi: 10.1007/BF02726113.
10
Improving diagnosis of childhood arterial ischaemic stroke.改善儿童动脉缺血性脑卒中的诊断。
Expert Rev Neurother. 2017 Dec;17(12):1157-1165. doi: 10.1080/14737175.2017.1395699. Epub 2017 Nov 7.

引用本文的文献

1
Current status and prognostic factors of paediatric arterial ischaemic stroke in China: a study protocol for Chinese Paediatric Ischaemic Stroke Registry (CPISR).中国儿童动脉缺血性卒中的现状及预后因素:中国儿童缺血性卒中登记研究(CPISR)方案
BMJ Open. 2025 Jun 18;15(6):e093718. doi: 10.1136/bmjopen-2024-093718.
2
Global, Regional, and National Burden of Stroke on Children and Adolescents Aged Under 20 Years From 1990 to 2021, With Projections of Disability-Adjusted Life Year to 2050: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家20岁以下儿童和青少年中风负担及到2050年伤残调整生命年预测:全球疾病负担研究2021的综合人口分析
Eur J Neurol. 2025 May;32(5):e70180. doi: 10.1111/ene.70180.
3

本文引用的文献

1
Constraint-Induced Movement Therapy for Cerebral Palsy: A Randomized Trial.强制性运动疗法治疗脑瘫:一项随机试验。
Pediatrics. 2021 Nov;148(5). doi: 10.1542/peds.2020-033878. Epub 2021 Oct 14.
2
Prevalence of Patent Foramen Ovale in a Cohort of Children With Cryptogenic Ischemic Stroke.不明原因缺血性卒中患儿队列中卵圆孔未闭的患病率
Neurology. 2021 Nov 23;97(21):e2096-e2102. doi: 10.1212/WNL.0000000000012892. Epub 2021 Oct 14.
3
Epidemiology of Stroke in Sickle Cell Disease.镰状细胞病的中风流行病学
Does Time and Experience Matter in Pediatric Arterial Ischemic Stroke (AIS) Intervention in Patients with an Initial Clinical Presentation of Mild/Moderate Severity? Long-Term Follow-Up Experience of a Single Tertiary Clinic.对于初始临床表现为轻/中度严重程度的小儿动脉缺血性卒中(AIS)患者,时间和经验在干预中起重要作用吗?一家三级诊所的长期随访经验。
Children (Basel). 2025 Mar 24;12(4):407. doi: 10.3390/children12040407.
4
Evobrutinib mitigates neuroinflammation after ischemic stroke by targeting M1 microglial polarization via the TLR4/Myd88/NF-κB pathway.依鲁替尼通过TLR4/Myd88/NF-κB途径靶向M1小胶质细胞极化,减轻缺血性中风后的神经炎症。
Mol Med. 2025 Apr 22;31(1):148. doi: 10.1186/s10020-025-01203-8.
5
Incident Stroke in Pediatric Sickle Cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and Ongoing Risks.在乌干达羟基脲试验中,尽管小儿镰状细胞贫血患者的经颅多普勒速度总体有所改善,但仍有卒中事件发生:既往及持续存在的风险。
Pediatr Blood Cancer. 2025 Jul;72(7):e31722. doi: 10.1002/pbc.31722. Epub 2025 Apr 22.
6
Chronic Intermittent Hypoxia-Induced Neural Injury: Pathophysiology, Neurodegenerative Implications, and Therapeutic Insights.慢性间歇性缺氧诱导的神经损伤:病理生理学、神经退行性变影响及治疗见解
CNS Neurosci Ther. 2025 Apr;31(4):e70384. doi: 10.1111/cns.70384.
7
Clinical and neuroimaging insights into childhood arterial ischemic stroke of different ages.不同年龄儿童动脉缺血性卒中的临床与神经影像学见解
Front Neurol. 2025 Apr 4;16:1568684. doi: 10.3389/fneur.2025.1568684. eCollection 2025.
8
Machine learning analysis of gene expression profiles of pyroptosis-related differentially expressed genes in ischemic stroke revealed potential targets for drug repurposing.对缺血性脑卒中中焦亡相关差异表达基因的基因表达谱进行机器学习分析,揭示了药物重新利用的潜在靶点。
Sci Rep. 2025 Feb 27;15(1):7035. doi: 10.1038/s41598-024-83555-5.
9
Incident Stroke in Pediatric Sickle cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and ongoing risks.尽管在乌干达羟基脲试验中经颅多普勒速度总体有所改善,但小儿镰状细胞贫血患者仍发生卒中:既往及持续风险
medRxiv. 2025 Jan 29:2025.01.28.25320389. doi: 10.1101/2025.01.28.25320389.
10
Intranasal delivery of hMSC-derived supernatant for treatment of ischemic stroke by inhibiting the pro-inflammatory polarization of neutrophils.经鼻递送人间充质干细胞来源的上清液通过抑制中性粒细胞的促炎极化来治疗缺血性中风。
Stem Cell Res Ther. 2025 Feb 4;16(1):43. doi: 10.1186/s13287-025-04172-1.
J Clin Med. 2021 Sep 18;10(18):4232. doi: 10.3390/jcm10184232.
4
A Prospective Multicenter Registry on Feasibility, Safety, and Outcome of Endovascular Recanalization in Childhood Stroke (Save ChildS Pro).儿童卒中血管内再通的可行性、安全性及结局的前瞻性多中心注册研究(拯救儿童卒中计划)
Front Neurol. 2021 Sep 3;12:736092. doi: 10.3389/fneur.2021.736092. eCollection 2021.
5
Review of treatment and therapeutic targets in brain arteriovenous malformation.脑动静脉畸形的治疗和治疗靶点综述。
J Cereb Blood Flow Metab. 2021 Dec;41(12):3141-3156. doi: 10.1177/0271678X211026771. Epub 2021 Jun 23.
6
Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration.Affinity 试验:氟西汀治疗急性卒中后功能恢复的 12 个月结局:Affinity 试验指导委员会代表 Affinity 试验协作组。
Stroke. 2021 Aug;52(8):2502-2509. doi: 10.1161/STROKEAHA.120.033070. Epub 2021 May 21.
7
Whole genome sequencing reveals a frameshift mutation and a large deletion in YY1AP1 in a girl with a panvascular artery disease.全基因组测序揭示一名泛血管疾病女孩 YY1AP1 中存在移码突变和大片段缺失。
Hum Genomics. 2021 May 10;15(1):28. doi: 10.1186/s40246-021-00328-1.
8
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism.PIK3CA 和 CCM 突变通过类似癌症的机制促进海绵状血管瘤的形成。
Nature. 2021 Jun;594(7862):271-276. doi: 10.1038/s41586-021-03562-8. Epub 2021 Apr 28.
9
Endovascular therapy for acute stroke in children: age and size technical limitations.儿童急性脑卒中的血管内治疗:年龄和大小的技术限制。
J Neurointerv Surg. 2021 Sep;13(9):794-798. doi: 10.1136/neurintsurg-2021-017311. Epub 2021 Apr 8.
10
Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies.干细胞治疗新生儿缺氧缺血性脑病的临床前研究的系统评价。
Int J Mol Sci. 2021 Mar 19;22(6):3142. doi: 10.3390/ijms22063142.